The influence of oxygen tension and pH on the expression of platelet- derived endothelial cell growth factor/thymidine phosphorylase in human breast tumor cells grown in vitro and in vivo

Cancer Research

Volumn 57, Issue 4, 1997, Pages 570-572

  Griffiths, Leigh ^a,c   Dachs, Gabi U ^a   Bicknell, Roy ^b   Harris, Adrian L ^b   Stratford, Ian J ^a,c  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; PLATELET DERIVED ENDOTHELIAL CELL GROWTH FACTOR; PRODRUG; THYMIDINE PHOSPHORYLASE;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL HYPOXIA; CELL PH; DRUG POTENTIATION; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; OXYGEN TENSION; PRIORITY JOURNAL; PROTEIN SYNTHESIS REGULATION; TUMOR NECROSIS;

ANIMALS; BREAST NEOPLASMS; CELL HYPOXIA; ENDOTHELIAL GROWTH FACTORS; HUMANS; HYDROGEN-ION CONCENTRATION; LYMPHOKINES; MALE; MICE; MICE, NUDE; THYMIDINE PHOSPHORYLASE; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0031058350     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Shweiki, D., Neeman, M., Itin, A., and Keshet, E. Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicellular spheroids: implications for tumor angiogenesis. Proc. Natl. Acad. Sci. USA, 92: 768-772, 1995.
2. Yumamoto, Y., Toi, M., Kondo, S., Mutsumoto, T., Suzuki, H., and Ktiamura, M. Concentrations of vascular endothelial growth factor in the sera of normal controls and cancer patients. Clin. Cancer Res., 2: 821-826, 1996.
3. Maeda, K., Chung, Y. S., Ogawa, Y., Takutsuka, S., Kang, S. M., Ogawa, M., Sawada, T., and Sowa, M. Prognostic value of vascular endothelial growth factor expression in gastric carcinoma. Cancer (Phila.), 77: 858-863, 1996.
4. Ishikawa, F., Miyazono, K., Hellman, U., Drexler, H., Wernstedt, C., Hagiwara, K., Usuki, K., Takaku, F., Risau, W., and Heldin, C. H. Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor. Nature (Lond.), 338: 557-562, 1989.
5. Toi, M., Hoshina, S., Taniguchi, T., Yamamoto, Y., Ishitsuka, H., and Tominaga, T. Expression of platelet-derived endothelial cell growth factor thymidine phosphorylase in human breast cancer. Int. J. Cancer, 64: 79-82, 1995.
6. Reynolds, K., Farzaneh, F., Collins, W. P., Campbell, S., Bourne, T. H., Lawton, F., Moghaddam, A., Harris, A. L., and Bicknell, R. Association of ovarian malignancy with expression of platelet-derived endothelial cell growth factor. J. Natl. Cancer Inst., 86: 1234-1238, 1994.
7. O'Brien, T., Cranston, D., Fuggle, S., Bicknell, R., and Harris, A. L. Different angiogenic pathways characterize superficial and invasive bladder cancer. Cancer Res., 55: 510-513, 1995.
8. Takebayashi, Y., Yamada, K., Maruyama, I., Fujii, R., Akiyama, S., and Aikou, T. The expression of thymidine phosphorylase and thrombomodulin in human colorectal carcinomas. Cancer Lett., 92: 1-7, 1995.
9. Moghaddam, A., Zhang, H. T., Fan, T. P. D., Hu, D. E., Lees, V. C., Turley, H., Fox, S. B., Gatter, K. C., Harris, A. L., and Bicknell, R. Thymidine phosphorylase is angiogenic and promotes tumor growth. Proc. Natl. Acad. Sci. USA, 92: 998-1002, 1995.
10. Miyazono, K., Okabe, T., Urabe, A., Takaku, F., and Heldin, C. H. Purification and properties of an endothelial cell growth factor from human platelets. J. Biol. Chem., 262: 4098-4103, 1987.
11. Iltztsch, M. H., Elkouni, M. H., and Cha, S. Kinetic studies of thymidine phosphorylase from mouse liver. Biochemistry. 24: 6799-6807, 1985.
12. Miyadera, K., Sumizawa, T., Haraguchi, M., Yoshida, H., Konstanty, W., Yamada, Y., and Akiyama, S. Role of thymidine phosphorylase activity in the angiogenic effect of platelet-derived endothelial cell growth factor/thymidine phosphorylase. Cancer Res., 55: 1687-1690, 1995.
13. 13'. Haraguchi, M., Miyadera, K., Uemura, K., Sumizawa, T., Furukawa, T., Yamada, K., Akiyama, S., and Yamada, Y. Angiogenic activity of enzymes. Nature (Lond.), 368: 198, 1994.
14. Madan, A., and Curtin, P. T. A 24-base pair sequence 3′ to the human erythropoietin gene contains a hypoxia-responsive transcriptional enhancer. Proc. Natl. Acad. Sci. USA, 90: 3928-3932, 1993.
15. Minchenko, A., Salceda, S., Bauer, T., and Caro, J. Hypoxia-regulatory elements of the human vascular endothelial growth factor gene. Cell. Mol. Biol. Res., 40: 35-39, 1994.
16. Griffiths, J. R. Are cancer cells acidic? Br. J. Cancer, 64: 425-427, 1991.
17. Takeuchi, M., Otsuka, T., Matsui, N., Asai, K., Hirano, T., Moriyama, A., Isobe, I., Eksioglu, Y. Z., Matsukawa, K., Kato, T., and Tada, T. Aberrant production of gliostatin platelet-derived endothelial cell growth factor in rheumatoid synovium. Arthritis Rheum., 37: 662-672, 1994.
18. Creamer, D., Jaggar, R., Allen, M., Bicknell, R., and Barker, J. Vascular proliferation and expression of the angiogenic factor platelet-derived endothelial cell growth factor thymidine phosphorylase (PDECGF/TP) in psoriasis. J. Invest. Dermatol., 706: 180, 1996.
19. Dachs, G. U., and Stratford, I. J. The molecular response of mammalian cells to hypoxia and the potential for exploitation in cancer therapy. Br. J. Cancer, 74: S126-S132, 1996.
20. Sheweiki, D., Itin, A., Soffer, D., and Keshet, E. Vascular endothelial growth factor induced by hypoxia-initiated angiogenesis. Nature (Lond.), 359: 843-845, 1992.
21. Takahashi, H., Uchino, J., Ogita, M., Sasaki, F., Hata, Y., Yoshimoto, M., Akasaka, Y., Nakanishi, Y., and Sawada, Y. Pyrimidine nucleoside phosphorylase activity and biological characteristics of breast cancer. Int. J. Oncol., 7: 1139-1144, 1995.
22. Bremner, J. C. M., Counsell, C. J. R., Adams, G. E., Stratford, I. J., Wood, P. J., Dunn, J. F., and Radda, G. K. In vivo P-31 nuclear magnetic resonance spectroscopy of experimental murine tumors and human tumor xenografts: effects of blood-flow modification. Br. J. Cancer, 64: 862-866, 1991.
23. Vandemerwe, S. A., Vandenbergblok, A. E., Kroon, B. B. R., and Vanderzee, J. Temporary vascular occlusion and glucose: effects on tumor and normal tissue pH in animal experiments. Int. J. Hyperthermia, 11: 829-839, 1995.
24. Patterson, A. V., Zhang, H., Moghaddam, A., Bicknell, R., Talbot, D. C., Stratford, I. J., and Harris, A. L. Increased sensitivity to the prodrug 5′-deoxy-5-fluorouridine and modulation of 5-fluoro-2′ deoxyuridine sensitivity in MCF-7 cells transfected with thymidine phosphorylase. Br. J. Cancer, 72: 669-675, 1995.
25. Schwartz, E. L., Baptiste, N., Wadler, S., and Makower, D. Thymidine phosphorylase mediates the sensitivity of human colon carcinoma cells to 5-fluorouracil. J. Biol. Chem., 270: 19073-19077, 1995.